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Shrimp aquaculture, an important industry worldwide, has been unfortunately 
devastated by the spread of viral pathogens during the last few decades. Shrimp white 
spot syndrome virus (WSSV) is the major pathogen out of the more than 20 reported viral 
agents causing huge economic losses to the industry worldwide. 
This project aimed to characterize and elucidate structures of representative proteins 
covering the nucleocapsid of the shrimp white spot syndrome virus. VP15, which is a 
major necleocapsid protein, was found to be a non-structural protein after in-vitro 
purification procedure. However, from the DNA-Protein interaction assay, the protein 
showed the ability to bind dsDNA. VP24, another supposed major nucleocapsid protein, 
was highly hydrophobic. A protocol was developed to solubilize and purify this protein. 
Furthermore, Anti-VP24 was also successfully produced and showed a high specificity.  
Future study of nucleocapsid proteins of WSSV can be focused on identification 
more nucleocapsid protein to achieve the capsid priteins in-vitro assembly. It will provide 













CHAPTER 1.  INTRODUCTION 
 
 
1. Literature Review 
 
1.1 Research Background 
 
Penaeid shrimp is one of the main seafood diets for human. Shrimp aquaculture has 
become an important industry worldwide and large-scale shrimp farming has arisen 
sharply due to huge consumer demands during the last few decades (Pa’ez-osuna et al., 
2001). In the year 2000 alone, the world's shrimp production totalled 4,168,400 tons and 
more than thirty species were cultured. However, intensive cultivation, inadequate 
sanitation of the shrimp industry and worldwide trade of life stock have unfortunately 
promoted the spread of vial pathogens. Shrimp diseases, especially those caused by 
viruses, present the biggest threat to the shrimp farming industry. 
Since baculovirus penaei was first discovered in 1974, approximately 20 shrimp 
viruses have been reported in cultured penaeid shrimp. Among them, white spot 
syndrome virus (WSSV), considered to be a new virus (Chen et al., 1997) and first 
appeared in the early 1990s in Taiwan, is the causative agent of a major pandemic that 
has led to severe mortalities of cultured shrimp worldwide (Lightner and Redman et al., 
1998). The economic loss is phenomenal in the range of multi-billion U.S. dollars and the 
disease has devastated the shrimp industry in many coastal countries in Asia and more 
recently in Central and South America. Clinical signs of the disease include a red color to 
the entire body and appendages along with small subcutaneous white spots. Histological 
examination reveals prominent intranuclear inclusion bodies in cuticular epithelium, 
subcutis and connective tissues. Except for the use of nonspecific immunostimulants such 
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as the bacterial glycans (with minimal protection) and low-density culture conditions, 
there is at present no effective treatment protocol for this disease. 
Most organs and tissues of shrimp, except for hepatopancreatocytes and epithelial 
cells of the midgut, can be infected by WSSV showing an obvious symptom of white 
spots on shrimp’s cuticle (Wang et al., 19999) (Fig.1.1). The virus has a broad host range, 
including other invertebrate aquatic organisms, such as crab and crayfish (Flegel et al., 
1997) (Fig.1.2). Therefore the virus is not only a major threat to the shrimp industry but 
also to the marine environment. 
 
1.2 WSSV (White Spot Syndrome Virus) 
 
Based on the morphology, genomic structure and composition and phylogenetic 
analyses, WSSV is a member of the genus Whispovirus within a new virus family called 
Nimaviridae, referring to the thread-like polar extension on the virus particle (Nima: 
Latin for thread). 
1.2.1 Biological Properties 
WSSV, circulating ubiquitously in the haemolymph of infected shrimp, can infect 
most organs and tissues, except for hepatopancreatocytes and epithelial cells of the 
midgut, which are regarded as refractory tissues (Wang et al., 1999). Upon infection, the 
viruses are observed first in the stomach, gill and cuticular epidermis of the shrimp, and 
subsequently in other tissues of mesodermal and ectodermal origins (Chang et al., 1996). 
WSSV has an extremely broad host range. Almost all the species of peneaid shrimp are 
susceptible to its infection. Moreover the virus can infect a wide range of aquatic 








Fig.1.1 WSSV infected shrimp     



































Fig.1.2 WSSV infected crab 
   (The presence of white spots on shrimp cuticle)               





























WSSV replication initiates in the nucleus, where virions are assembled. The virions 
are released from the infected cell by cell rupture. Infected animals show gross signs of 
lethargy, such as lack of appetite and slow movement. Characteristic for infected shrimps 
are the white spots on the exoskeleton. 
1.2.2 Microheterogeneity in WSSV Isolates 
Only a single species within the genus Whispovirus has been identified today 
(WSSV). Various geographical isolates with genotypic variability (variants) have been 
identified within this species. Other names that are used in literature for WSSV include 
HHNBV (hypodermal and hematopoietic necrosis baculo-like virus of P. chinensis), 
RV-PJ (rod-shaped virus of Penaeus japonicus), SEMBV (systemic ectodermal and 
mesodermal baculovirus) and WSBV (white spot Bacilliform virus).  
1.2.3 Morphology 
Virions of the type species of Whispovirus, WSSV, are large, ovoidal particles of 
about 300-350 nm in length and 70-120 nm in width, with a tail-like appendage at one 
end (Fig1.3 and Fig1.4). The virion consists of a rod-shaped nucleocapsid with a 
tight-fitting capsid layer surrounded by a double envelope (Fig.1.5). Isolated 
nucleocapsids have a crosshatched appearance and a size of about 300 x 70 nm. A 
multifilament appendage is often seen attached at the narrow end in the purified virion 
(Huang C et al., 2001), which is excluded in the intact virion from the direct negative 
staining of WSSV-infected shrimp hemolymph (Wongteerasupaya et al., 1995). The 
nucleocapsid, which contains a DNA-protein core bounded by a distinctive capsid layer, 











Fig.1.3 Electron micrographs of purified intact WSSV virions  




































Fig.1.4 Nucleocapsids of WSSV 













































DNA replication and de novo envelop formation of WSSV take place in the nucleus. 
(Durand et al., 1997; Wang CH et al., 2000). 
1.2.4 Virion Proteins 
    In general, the viral proteins are divided into three temporal classes: early proteins 
synthesized prior to the replication of the DNA, and the intermediate and late proteins 
synthesized after the onset of DNA replication (Jensen et al., 1996). The late proteins 
synthesized from 5 to 6 h post-infection are assumed to be viral structural proteins. 
Based on the separation of the proteins from the purified WSSV virions by 
SDS-PAGE, more than 20 bands ranging from 5~ 190 kDa were visible with Coomassie 
blue staining (Fig 1.6) (Huang et al., 2002a). In an attempt to identify the viral proteins 
from the 181 theoretical ORFs, proteins of the purified WSSV were separated by 
two-dimensional gel electrophoresis (2-DE). More than sixty protein spots were revealed 
as detected by silver staining. 
Structural proteins including the envelope proteins and nucleocapsid proteins, are 
important due to their involvement in the interaction between virus and host, such as 
attachment to receptors and fusion with cell membranes. Up to date, at least 5 genes 
encoding major structural proteins of WSSV have been reported and been named 
according to their sizes in SDS-PAGE (Zhang et al., 2002a, 2002b; Huang et al., 2002a, 
2002b). The envelope contains three major proteins, VP28, VP19 and VP26, whereas the 
nucleocapsid contains two, VP24 and VP15 (Fig.1.7). VP28 is most likely located on the 
surface of the virus particle and plays a key role in WSSV infection. A putative function 
of VP15, a highly basic protein with no hydrophobic regions, is that of a histone-like, 










































Fig.1.7 Coomassie brilliant blue-stained SDS–15% PAGE gel of purified 
WSSV. 
Lane 1, low molecular mass protein marker. Lane 2, mock purification 
(uninfected). Lane 3, purified WSSV particles (including envelope proteins 

























    WSSV is at present the largest animal genome that has been entirely sequenced. 
Sequencing of three different isolates revealed that the circular dsDNA genome contains 
around 305 kb (Fig.1.8). The genome has a G+C content of 41% uniformly distributed 
over the genome. Three percent of the WSSV genome consists of nine homologous 
regions (hrs) dispersed throughout the genome with different sizes, while the remaining 
97% of the sequences are unique (Yang et al., 2001; van Hulten et al., 2001). The WSSV 
genome has the capacity to encode 181 presumptive open reading frames (ORFs) of 50 
amino acids or more, ranging from 61 to 6077 amino acids (Yang et al., 2001). Since the 
origin of replication is unknown, a guanine residue from the beginning of the largest 
BamHI fragment is designated as the starting point of the physical map of the WSSV 
genome (Yang et al., 2001). The ORFs are present on both strands in almost equal 
proportions (54% forward, 46% reverse). A TATA box sequence is found in the promoter 
regions of 46% of the WSSV ORFs. Consensus poly (A) signal sequence can be found for 
80% of the ORFs. 
Several unique features of the WSSV genome are the presence of a very long ORF 
of 18,234 nt, with unknown function, a collagen-like ORF, and nine non-coding regions, 
dispersed along the genome, each containing a variable number of 250 bp tandem repeats. 
1.2.6 Phylogeny 
Based on the phylogenetic trees of the WSSV genes DNA polymerase (see figure 
1.9), ribonucleotide reductase large (rr1) and small (rr2) subunits, protein kinase, 
thymidine-thymidylate kinase and endonuclease, no recent relationship was revealed for 
































































Fig.1.9 Bootstrap analysis (100 replicates) of an uprooted phylogenetic tree of the 
WSSV protein DNA polymerase. 
The numbers at the branches indicate frequency of the clusters and frequencies  
























2. Structural Genomics  
 
The explosive growth of genetic sequence information has offered us comprehensive 
collections of the protein sequences found in many living organisms. Most of these 
proteins are not experimentally characterized. Although half of the proteins that are 
encoded in sequenced eukaryotic genomes have computationally recognized homology to 
at least one well-characterized domain (Lander, E. S. et al.， 2001), functional 
interpretation of these matches is fraught with difficulty. Functional changes over 
evolutionary time (Devos, D. and Valencia et al.，2000) and database errors (Brenner et 
al., 1999) confound reliable computational prediction of the precise roles of newly 
discovered genes. Even proteins with recognized domains are often scattered with regions 
of unmatched sequence. Therefore, most of the residues in putative gene products lack 
any computational annotation, and there exists no general experimental approach to 
directly ascertain their molecular role. The challenge of understanding these gene 
products has led to the development of functional genomics methods, which collectively 
aim to improve the genetic sequence with biological understanding. Structural genomics 
is one such approach, with unique promise to reveal the molecular function (Ashbumer, 
et al., 2000) of protein domains. 
Structural genomics projects aim to provide an experimental or computational three 
dimensional model structure for all of the tractable macromolecules that are encoded by 
complete genomes. Their experimental structures and computational models are expected 
to yield new insight into the molecular function and mechanism of thousands of proteins. 
(Steven E. Brenner et al., 2001) 
2.1 Technology 
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Structural biologists have embraced high-throughput biology by developing and 
implementing technologies that will enable the structures of hundreds of protein domains 
to be resolved in a relatively short period of time. There are now many new developments 
in X-ray crystallography, NMR spectroscopy, cryoelectron microscopy, robotic 
crystallization, high performance computing, PCR recombinant technology and 
high-level protein expression system. These advancements have made it feasible to 
mount a system/organism-specific structural biology program to determine the three 
dimensional structures of the majority if not all proteins in a particular organism (Burley 
et al., 1999; Chance et al., 2002). Structural Genomics, this new concept is now being 
developed in many laboratories. This large scale, high throughput concerted effort will 
attempt to determine the structures of representative proteins (in terms of protein domain 
and folding) and should provide a better understanding of the physiology of the organism 
under investigation. Besides elucidating the functions of the presumptive proteins based 
on the determined structures (Sharpiro et al., 2000; Norin and Sundstrom et al., 2002), 
the study will also provide the structural information necessary for drug targeting and 
design. 
2.2 Process 
The principles of experimental structural genomics are largely the same as those for 
traditional structural biology, but differ in motivation, automation and scale (Fig.1.10). 
The key to the success of this scientific venture is the ability to optimize the 
structure-determination process, so as to reap economies of scale as centres increase their 
throughput. The flow of information and material between projects of one structural 


































Fig.1.11 Processes involved in high-throughput structural genomics using 
X-ray crystallography.  N indicates that a process has failed and Y that it 
has succeeded. (MIR, multiple isomorphous replacement; an alternative to 
multiple anomalous dispersion (MAD) phasing for structure determination; 





Structural genomics provides a solid foundation for the future of structural biology 
research. It will revolutionize biochemistry and molecular biology, making use of the 
three-dimensional structure information. Just as one can expect to find sequences for 
most genes of interest in public databases, structural genomics promises to offer a 
comparably comprehensive library of experimental and computational models. These will 
reveal new functions, indicate molecular mechanisms and explicate mutations. 
2.3 WSSV as A Model for Structural Genomics Study 
WSSV provides an important and interesting model for structural genomics study. It 
has a relatively small genomes with only approximately 181 opening reading frames, 
much smaller than many of the organisms such as Mycoplasma genitalium, 
Mycobacterium tuberculosis, Saccaromyces cerevisiae, E.coli (Escherichia coli) and C. 
elegans selected for similar structural genomic studies ( Chance et al., 2002 ). This would 
make the study more manageable for a small research team in Singapore. 
Many of WSSV presumptive ORFs do not have any match with known proteins and 
functions. Structural genomics therefore offers a unique opportunity to elucidate the 
function of these proteins through structural determination and prediction. Structural 
elucidation of WSSV will provide many insightful mechanisms of host-pathogen 
interaction, the maturation and assembly of the virus particles and many other important 








3. The Objective of This Research 
The characterization of the structural proteins and their genomic sequence is of 
major importance to determine the taxonomic position of the virus. The project aims to 
elucidate the three dimensional structure of the virus capsid protein and its assembly. The 
structures of representative proteins (in terms of protein domain and folding) should 
provide a better understanding of the physiology of the organism under investigation. 
Furthermore, the structure and interaction of the capsid proteins may explain the unique 
morphological features of this virus. Besides elucidating the functions of the presumptive 
proteins based on the determined structures, this study will also provide the structural 













CHAPTER 2. NUCLEOCAPSID PROTEIN VP15 OF WSSV 
1. Summary  
DNA fragment encoding the proteins VP15 was PCRed out from WSSV genomic 
DNA and cloned into pGEX-6P-1 vector (N-terminal GST-tagged) with restriction sites 
BamHI / Xho I. The sequence confirmed vector was transformed into BL21 cell for 
expression. Over-expressed and soluble proteins was further 15N isotope-labeled by 
growing BL21 cells in the M9 medium with 15N -ammonium sulfate as the sole nitrogen 
source. The GST fusion protein was purified by affinity chromatography on the 
glutathione Sepharose 4B beads. The N-terminal GST tag was cleaved by PreScission 
Protease on-column at 4 ℃ degree with overnight incubation. Pre-equilibrium SP 
Sepharose column was used for further purification of this extremely basic protein. 
Collected protein was confirmed as target VP15 by N-terminal sequence. The purified 
VP15 was further used to perform NMR experiments. The two-dimensional NMR 1H-15N 
Heteronuclear Single-Quantum Correlation (HSQC) Spectra was collected for 15N 
isotope-labeled samples. Gel mobility shift assay were further carried out to determine 
whether there were any specific DNA binding site for VP15. CD spectroscope was used 







2. VP 15 
2.1 Introduction 
Previous studies showed the virion nucleocapsid consists of three major proteins of 
VP26, VP24 and VP15 (Van Hulten et al., 2001a). However, based on the experimental 
result of our lab, VP26 is not a capsid protein, but rather an envelope protein. So 
nucleocapsid of WSSV virions presumably consists of two major proteins VP15 and 
VP19. 
2.2 Sequence and Location of the 15 kDa Protein Gene on the WSSV 
Genome 
The complete sequence of WSSV has recently been determined (Van Hulten et al., 
2001a; Yang et al., 2001) and the N-terminal amino acid sequence determined for VP15 
was found to be encoded by ORF109. This ORF is located as a single-copy gene from 
nucleotide position 163996 to 164238 on the WSSV genome. It partially overlaps with a 
small putative ORF of 11 kDa, ORF110, which is in the reverse orientation on the WSSV 
genome (Fig. 2.1). Both ORFs are flanked by two large ORFs (ORF108 and ORF111), 
encoding putative proteins of 174 and 132 kDa, respectively. The experimentally 
determined N terminus of VP15 is not located at the putative start of ORF109, but at the 
valine at position 21, which is the amino acid following the methionine encoded by the 
second ATG (Fig. 2.2). The first ATG of this ORF is apparently not used (Van Hulten et 
al.2002), This ATG is in an unfavourable Kozak (1989) context (TTCATGA) for 
efficient translation initiation, whereas the second ATG is in a favourable Kozak context 
(AAAATGG). 
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Fig.2.2 Nucleotide and protein sequence of VP15. (The N-terminal 
sequenced amino acids are in bold type, the location of the putative 















position relative to a putative transcriptional start, which also favours this second ATG. 
As no signal peptide was predicted for the first nor for the second ATG, the most likely 
explanation for the presence of the valine at the N terminus is the removal of the 
N-terminal methionine by N-terminal processing enzyme(s) as is observed for more than 
60% of eukaryotic and prokaryotic proteins (Giglione et al., 2000). When the second 
residue is a valine, removal of the N-terminal methionine is favoured (Flinta et al., 1986). 
A poly(A) signal is present 62 nucleotides downstream of the translation stop codon 
(Fig.2.2). ORF109, starting at the preferred (second) ATG, encodes 61 amino acids. 
2.3 Characteristic of Protein VP15 
The theoretical molecular mass of the 60 amino acid protein after removal of the 
N-terminal methionine is only 7102.26Da, but it migrates as a 15 kDa protein in SDS 
PAGE. Its aberrant migration may be caused by the fact that this viral protein has an 
extreme basic pI value of 13.2. The protein has an amino acid composition rich in lysine 
(22 %), arginine (23%) and serine (25 %). No potential sites for N-linked glycosylation 
(N-²P´-[ST]-²P´) or for O-glycosylation (Hansen et al., 1998) could be identifed. Eight 
possible phosphorylation sites ([ST]-X-X-[DE] or [ST]-X-[RK]) were found within VP15. 
No cysteine residues are present, and therefore VP15 is unable to form any disulfide 
bridges. No hydrophobic regions are present in this protein (Fig. 2.3) and it has a strong 
positive charge along the whole length of the polypeptide. 
A putative function for this highly basic protein is that of a histone-like, 
DNA-associated protein. Its small size, positive charge at physiological pH (26.9 at pH 
7.0) and its presence within the nucleocapsid fraction are in agreement with this 











Fig.2.3 Hydrophilicity plots of VP15    
     















VP15 has homology with several DNA-binding proteins of eukaryotic origin. 
Comparison of VP15 with DNA-binding proteins of baculoviruses, e.g. with AcMNPV 
DNA-binding protein p6.9 (Wilson and Price et al., 1988) and Lymantria dispar MNPV 
(LdMNPV) DNA-binding protein p6.9 (Kuzio et al., 1999), revealed an overall pair wise 
amino acid sequence similarity & identity of 47% & 26% with AcMNPV and 45%& 27% 
with LdMNPV. This homology with other DNA-binding proteins is the result of the high 
content of basic amino acids (e.g. arginine) and serine, characteristic of these proteins. 
This further substantiates the putative function of VP15 as a DNA-binding protein. 
2.4 Studies on VP15 
This study aims to select proper expression system to express VP15 and to use 
chromatography for its purification. Furthermore, gel mobility shift was also studied for 
DNA-protein interaction, to identify whether there is any specific DNA binding site. 
Some structural biology technologies, such as, NMR (nuclear magnetic resonance), CD 











3. Introduction to Biomolecular NMR 
When a sample is placed in a magnetic field and is subjected to radiofrequency at an 
appropriate frequency, nuclei in the sample will absorb the energy. Absorption of energy 
by the nuclear spins causes transitions between different energy levels. The energy 
absorbed by the nuclear spins induces a voltage that can be detected by a suitably tuned 
coil of wire, amplified and then the signal displayed as free induction decay. 
The NMR phenomenon was first detected by Bloch and Purcell independently 
(Bloch et al., 1946; Purcell et al., 1946). In order to induce magnetic resonance, an 
oscillatory magnetic field has to be applied at the frequency which corresponds to the 
difference between two energy levels of the nuclear spins. This was originally achieved 
by scanning various different frequencies (continuous wave or CWNMR). A major 
breakthrough in NMR technology is the concept of Fourier Transform NMR spectroscopy 
(Ernest and Anderson et al., 1966). In FTNMR, all spins of a particular isotope can be 
excited in one experiment and the resulting resonance signals can be converted to 
frequency spectrum via Fourier Transform. FT NMR is therefore more time efficient and 
sensitive. 
NMR spectroscopy was firstly used for the structural determination of small 
molecules in organic chemistry. The study of protein by NMR was hampered until the 
late 1970s. This is mainly because a large number of protons that a protein contains will 
make the 1D proton spectrum extremely overlapped and largely uninterpretable. The 
application of 2D spectra makes it possible to study small proteins by NMR. In 
two-dimensional NMR spectroscopy the second dimension is another time domain which 
can be established by introducing another pulse and systemically increase the time 
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between the two pulses.  
The strategy for protein structural determination by 2D experiments was first 
developed by Wuthrich and his colleagues in the early 1980s (Wuthrich et al., 1986). The 
two dimensional NMR spectra are useful for determining structure of proteins with less 
than 80 amino acid residues. However, with the increasing molecular weight of protein, 
the 2D spectra become severely overlapped and crowded. This render it is impossible to 
identify adjacent spin systems by only utilizing a single common resonance frequency of 
the connecting cross peaks. 
Since 1990s, significant progress has been made for determining protein structures 
using multidimensional NMR experiments. Compared with the NMR structures of 10 
years ago, the structures being determined today have much higher molecular weight, 
precision and are completed much faster. A lot of technological advances are required for 
the improvements. Some of the most important aspects are certainly the availability of 
high field spectrometers (500-900MHz) and multidimensional techniques. Equally 
important are the development of multi-channel spectrometer hardware, indirect detection 
and the application of cryoprobes. Other advances include improvements in computers 
hardware and software, plus advances in techniques for calculating protein structures 







4. Introduction to Circular Dichroism 
Inherently asymmetric chromophores (uncommon) or symmetric chromophores in 
asymmetric environments will interact differently with right- and left-circularly polarized 
light resulting in two related phenomena. Circularly-polarized light rays will travel 
through an optically active medium with different velocities due to the different indices 
of refraction for right- and left-circularly polarized light called optical rotation or circular 
birefringence. The variation of optical rotation as a function of wavelength is called 
optical rotary dispersion (ORD). Right- and left-circularly polarized light will also be 
absorbed to different extents at some wavelengths due to differences in extinction 
coefficients for the two polarized rays called circular dichroism (CD). Optical rotary 
dispersion enables a chiral molecule to rotate the plane of polarized light. ORD spectra 
are dispersive (called a cotton effect for a single band) whereas circular dichroism spectra 
are absorptive. The two phenomena are related by the so-called König-Kramers 
transforms. 
The phenomenon of circular dichroism is very sensitive to the secondary structure of 
polypeptides and proteins. Circular dichroism (CD) spectroscopy is a form of light 
absorption spectroscopy that measures the difference in absorbance of right- and 
left-circularly polarized light (rather than the commonly used absorbance of isotropic 
light) by a substance. It has been shown that CD spectra between 260 and approximately 
180 nm can be analyzed for the different secondary structural types: alpha helix, parallel 
and antiparallel beta sheet, turn, and other (Fig.2.4). Modern secondary structure 
determinations by CD are reported to achieve accuracies of 0.97 for helices, 0.75 for beta 
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sheet, 0.50 for turns, and 0.89 for other structure types (Manavalan and Johnson et al., 
1987).  
Besides defining the secondary structure characteristics of proteins and peptides, CD 
can also provide rapid structural comparisons (e.g. between mutants), is ideally suited to 
exploring the extent and rate of structural changes, and can probe interactions 
(protein-ligand; protein-protein; protein-nucleic acid etc.). The full potential of CD is 






















































5. Material and Methods 
 
Construction Plasmid of 6P-1-VP15 
183 bp DNA fragment encoding the proteins was amplified out from WSSV 
genomic DNA using PCR and cloned into pGEX-6P-1 vector (N-terminal GST-tagged) 
with restriction sites XhoI and BamHI. 
5.1 PCR Amplification of Gene VP15 
  
VP15 DNA Sequence: 
5’ atggttgccc gaagctccaa gaccaaatcc cgccgtggaa gcaagaagag gtccaccact 
gctggacgca tctccaagcg gaggagccca tcaatgaaga agcgtgcagg aagaagagc 
tccactgtcc gtcgccgttc  ctcaaagagc  ggaaagaagt  ctggagcccg  caagtcaagg 
cgttaa  3’  
The 183 bp gene was PCR amplified by two primers (5’-:CGC GGA TCC  GTT 
GCC CGA AGC TCC AAG -3’ and 5’- CGC CCG CTC GAT TTA ACG CCT TGA 
CTT GCG GGC -3’) from the pGEX-6P-1vector. The primers used in the PCR were 
specially designed to incorporate XhoI and BamHI restriction sites to the flanks of the 
VP15 fragment for subsequent cloning into the expression vectors. (Table2.1& Table 2.2) 
5.2 Construction of 186bp PGEX 6P-1-VP15 Gene  
The PCR fragment (5 µL) was run on a 1.5 % agarose gel. 45µL PCR product was 
purified and concentrated by ethanol precipitation. Both the amplified VP15 fragment 
and the pGEX-6P-1 plasmid vector were doubly digested (Table 2.3) with XhoI and 
BamHI restriction enzymes (New England Biolabs). The cut DNA fragments were 




Components                      Volume (µL) 
DNA template(WSSV genome)             1 
Pfu DNA Polymerase 10X Buffer with MgSO4    5 
Forward Primer (10 µM)              1 
Reverse Primer (10 µM)              1 
dNTP (10 µM each)               1 
Pfu DNA Polymerase (3 U/µL)             1 
Deionized water                  40 
 Total      50 













































 Step  Cycle  Temperature (oC)  Time 
1  1           95    1min 
2      30              94    30 s 
50           30 s            
72           30 s 
3  1          72      15 min 
4  1          15       Hold   
  




Components                      Volume (µL) 
XhoI                                             1 
BamHI                                           1 
Buffer 2 (10X)                                     2 
BSA (10X)                                        2 
DNA (vector / insert)                              6/14 
Deionized water                  8/0 
 Total      20 
 





















Vector was dephosphorylated. A 1:3 molar ratio of vector: insert was used for the 
cloning of the VP15 into vectors. The ligation was performed at 16℃ for 18 h.  
Ethanol Precipitation 
45µL PCR product was mixed with 55 µL water.  Same volume CH3Cl was added. 
10 µL NaAC was applied to the sample. 2.5 Volume 100% ethanol was added to the 
mixture and left it at -80  ℃ for 10 mins. After discarding the supernatant, 2.5 volume 70% 
ethanol was further added to the tube and centrifuge at 13,000 rpm for 10 mins. 
Supernatant was discarded and the tube was dried on 50-60  ℃ by heat block. 20 µL M.Q 
water was added to get the concentrated DNA. 
Vector Dephosphorylation 
The mixture of all components (Table 2.4) was incubated at 37  ℃ for 30 mins. 
Another 2µL Apase stock was added and incubated at 37  ℃ for 30 mins again. The 
sample was kept at in 75-85  ℃ for 10 mins and later at room temperature. 
Gel Extraction 
DNA was run on 1.5% agarose gel. The DNA fragment was excised from the gel and 
weighed. The 300 µL buffer QG was added to 100 µL gel, and incubated at 50  ℃ for 10 
mins (mix every 2-3 mins by votex). 100 µL isopropanol was added to the sample and 
loaded the mixture to the QIA quick column, centrifuged for 1 min. 0.7 mL of buffer PE 
was added and centrifuged for 1 min. The flow through was discarded. Finally, QIA quick 
column was placed into a clean 1.5 mL microcentrifuge tube. The DNA was eluted with 
20 µL water. 
Ligation 





Components                      Volume (µL) 
Digested Vector DNA                                20 
10X Apase stock ( Alkaline Phosphatase)                 2 
(Buffer: 0.5 µL, Apase: 0.5µL, Water: 4µL)  
Buffer (10X)                                        3 
Deionized water                    5 
 Total       30 
 





















pGEX-6P-1 vector using 1:2 molar ratio of vector: insert. The ligation reaction (Table 2.5) 
was performed at 16  ℃ for 18 h. 
Preparation of Competent E. coli Cells 
A tube of glycerol stock of DH5-α E. coli cells was thawed and 50 µL was used to 
innoculate 2 mL of Lauria Bertiani (LB) medium. This was shaken in a 37℃ incubator 
set at 230 rpm for 18 h. Of this culture, 100 µL was transferred to 250 mL of LB medium 
and left to shake at 230 rpm at 37 ℃ till the optical density at 600 nm (OD600) reached a 
value of 0.3 to 0.6. The bacterial culture was centrifuged at 4000 x g for 15 min at 4 ℃. 
The pellet was resuspended on ice in 1/20 volume TSS [LB broth (pH 6.1), 10 % 
polyethylene glycerol, 5 % DMSO (dimethylsulfoxide, Sigma) 10 mM MgCl2, 10 mM 
MgSO4; final pH 6.5]. The competent cells were kept on ice for 10 min, then aliquoted in 
100 µL and snap-frozen in liquid nitrogen before storage at -80℃. 
Transformation of E.coli Competent Cells  
100 µL competent cell was thawed on ice before the ligation mixture was added. 
The cells were kept on ice for 30 minutes. After heat shock at 42℃ for exactly 60 
seconds, the cells were kept on ice for an additional 2 minutes. 800µL LB medium was 
added to the cells and mixed by inverting up and down. The cells need to be incubated at 
37℃ for 1 hour before plated onto LB agar plate. The plate was incubated overnight at 
37℃. 
Small Scale Plasmid DNA Isolation and Purification 
Selected colonies were grown in 5 mL LB medium supplemented with 100 µg/µL 










Components                    Volume (µL) 
T4 DNA ligase                       1 
10X T4 DNA Ligase buffer                        2 
Dephosphorylated vector                          6 
Insert                                         11 
 Total                                         20 
   












followed by centrifuging 5 mL of the cultures at 10,000 x g for 10 min. The plasmid DNA 
was extracted using the Minipreps DNA Purification System (QIAgene). 
Pelleted bacterial cells were resuspended in 250 µL P1 buffer.  250 µL P2 Buffer 
were added and the tube was inverted 4-6 times in less 5 mins.  350 µL N3 Buffer was 
added and inverted 4-6 times. The content was centrifuged for 15 mins at 4℃ at 13,000 
rpm. Supernatant was applied to a QIA prep column, centrifuged for 30- 60 s and the 
flow through was discarded.  QIA prep spin column was washed by 0.5 mL Buffer PB 
and centrifuged for 30-60 s and flow-through was discarded. To remove residual wash 
buffer another centrifuge was done to the spin column. To elute the DNA, 50 or less M.Q 
water was added to the center of QIA prep column and centrifuged for 1 min.  
Analysis of DNA Purity and Concentration 
To analyze the amount and purity of DNA, spectrophotometric readings at OD260 nm 
and OD280 nm were taken after DNA purification. The ratios of OD260 nm /OD280 nm were 
taken as the basis of DNA purity.  
Verification of 6P-1-VP15 Construct  
The plasmid DNAs and control vector were digested with BamHI and XhoI 
restriction enzyme (New England Biolabs), according to the instructions (same as above). 
Each reaction mixture was incubated at 37℃ for 2 h. The reaction mixtures were stopped 
by heating at 75℃ for 15 min. 5 µL of each reaction mixture was analyzed by gel 
electrophoresis to verify for the correct size.  
DNA Sequencing of the PCR Fragment  
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The PCR fragment clone was then sequenced using BigDye® Terminator v 3.0 Cycle 
Sequencing kit from both sense and antisense orientations. The DNAMAN sequence 
analysis software (Lynnon BioSoft, version 4.15) was then used to assemble and analyze 
the DNA sequences obtained. The components and cycling parameters of the sequencing 
reaction are shown in Table 2.6 and 2.7 respectively. 
5’ pGEX Sequencing Primer   5’-d[GGGCTGGCAAGCCACGTTTGGTG]-3’ 
3’ pGEX Sequencing Primer   5’-d[CCGGGAGCTGCATGTGTCAGAGG]-3’ 
 
 
The precipitation of the PCR fragment was carried out according to the following 
protocol.  
80 µL mixture (3 µL 3M NaOAC pH: 4.6; 62.5 µL Non-denatured 95% ethanol; 
14.5 µL deonized water) was added to the PCR products and stood for 15 mins. The tube 
was spinned at Max speed for 20 mins and the supernatant was discarded. 500 µL 70% 
Ethanol was added and kept still for another 15 mins. The tube was spined for 5 mins at 
13,000 rpm and the supernatant was aspirated carefully. The tube was left to dry 
thoroughly overnight. 
Automated sequencing was then performed using the ABI Prism® 3100 DNA 
Automated Sequencer (Perkin Elmer).  
5.3 Expression System of 6P-1-VP15 
Transformation Plasmid 6P-1-VP15 into Expression Competent Cell BL21 (DE3) 
The DNA plasmid (1 µL) was added to 100 µL KCM (100 mM KCl, 30 mM CaCl2, 
50 mM MgCl2). Frozen BL 21 competent cells (100 µL) were added to the DNA/KCM 
mixture. The mixture was gently mixed, kept on ice for 30 mins and plated onto a LB 



























 Components                  Volume (µL)
Double-stranded DNA template (0.4 µg)     1  
Terminator Ready Reaction Mix       4 
Primer (10 pmol)                1 
Deionized water                4     
Total   10 





Step  Cycle  Temperature (oC)  Time 
1   25          95        30 s  
50          5 s 
60       4 min 
2              4        Hold  
























Determination of Target Protein Solubility 
A single colony was picked up from plate to inoculate 5 mL LB medium containing 
100ug/mL ampicilin (LBA) and grown overnight at 37℃ with shaking. 2.5 mL overnight 
culture was further inoculated into 50 mL LBA and grown with vigorous shaking until the 
OD600 was about 0.5. 1 mL sample (non-induced control) was taken out, centrifuged and 
resuspended in 50 µL SDS-PAGE sample buffer. IPTG was added to the rest of culture to 
a final concentration of 0.5 mM to induce protein expresssion for further 3-3.5 hours. 1 
ml sample was collected, centrifuged and resuspended in 100 µL SDS-PAGE sample 
buffer. The rest of culture was harvested and centrifuged at 5000 rpm for 10 minutes at  
4℃. The cell pellet can be resuspended in 5 mL lysis buffer and further sonicated 
thoroughly. The lysate was centrifuged at 16,000 rpm for 20 minutes. 100 µL supernatant 
(soluble) was taken out and added to 100 µL 2 × SDS-PAGE sample buffers. Alquots of 
pellet (insoluble protein) were resuspended in 100 µL 2 × SDS-PAGE sample buffer.  
All the 4 samples were boiled for 5 minutes and microcentrifuged. 10 µL of 
supernatant was loaded into each lane of the SDS-PAGE gel. 
Unlabeled Protein Expression 
For unlabeled protein, a single colony of host cell harboring the construct 
6P-1-VP15 was picked up from the agar plate and inoculated into 10 mL LB medium 
containing 100µg/mL ampicillin. The overnight culture was further inoculated into 1 liter 
fresh LB medium with the same concentration of ampicillin. The cells were grown at 
370C with vigorous shaking until the O.D.600 reached about 0.5. IPTG (isopropyl 
-D-thiogalactoside) was then added to a final concentration of 0.5 mM to induce the 
expression for an additional 3 hours. The cells were harvested by centrifugation at 5000 
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rpm for 20 minutes. The cell pellet was kept frozen at -20℃ or directly resuspended in 
lysis buffer for further purification. 
15N Uniformly Labeled Sample 
The production of 15N uniformly labeled sample is similar to that of unlabeled 
sample, except that M9 minimal media containing 15N NH4Cl and 12C glucose as the sole 
nitrogen source and the carbon source was used to grow the cell. Protein experiment was 
induced at a cell OD600 around 0.4-0.5. Long induction time (4 hours) is used to increase 
the yield of expressed protein. 
1 liter M9 minimal medium contain: 1 g NH4Cl, 1 g Glucose, 0.0147g CaCl•2H2O, 
0.493 MgSO4•7H2O, 7.52g Na2HPO4, 3g KH2PO4, 0.5g NaCl.  
5.4 Protein Purification  (Fig. 2.5) 
5.4.1 Pre-Column Treatment 
Resuspended pellet in 20mL of lysis buffer [ 2mM DTT, 500mM NaCl, 1mM EDTA, 
pH 8.0 (adjusted by Tris)] was sonicated thoroughly and then inclusion bodies and cell 
debris were spun down at 18,000 rpm for 30 minutes. The supernatant was discarded and 
the pellet was resuspended in 20mL GST column binding buffer (the same as lysis buffer). 
The insoluble cell debris was removed by centrifugation. 
5.4.2 GST (glutathione S-Transferase) Affinity Chromatography 
The soluble denatured protein was loaded into a 2mL GST resin column which had 
been equilibrated with binding buffer. After the GST-tagged protein was bound onto the 
resin, the resin was further washed thoroughly with 30 mL washing buffer [2mM DTT, 
500mM NaCl, 1mM EDTA, pH 8.0 (adjusted by Tris)] until the absorption at 280 nm of 
















 GST-tagged protein can be eluted out by a small amount of elution buffer [2mM 
DTT, 500mM NaCl, 1mM EDTA, 20mM reduced glutathione pH 8.0 (adjusted by Tris)]. 
For every step, 0.5 mL sample was collected and boiled with SDS loading buffer to be 
further checked by SDS-PAGE. 
5.4.3 PreScission™ Protease Cleavage  
The yield and concentration of protein was estimated by measuring absorbance at 
230nm. GST-tag can be removed by cleavage with PreScission™ Protease at 4℃ 
overnight. The completion of cleavage was checked by SDS-PAGE. Cleaved protein wish 
GST and PreScission™ Protease was dialyzed and loaded to column with GST resin 
again to remove the GST and protease.  
5.4.4 Ion Exchange Column  
The flow through which contained protein VP15 was then loaded onto a SP 
Sepharose column. The mobile phase was equilibrated by washing buffer. A slow flow 
rate (0.5mL/min) of elution buffer [2mM DTT, 2M NaCl, 1mM EDTA, pH 8.0 (adjusted 
by Tris)] was used to run the column. The fractions with the highest absorbance at 280 
nm were pooled. The purity of the fractions was checked by SDS-PAGE and the most 
purified fractions were pooled and dialyzed in buffer to remove NaCl. The purified 
protein was buffer exchanged to NMR buffer (50mM phosphate buffer with 10% D20, pH 
6.0 and 0.5 M Na2SO4) by ultra-filtration using Centriprep3 (Milipore) and concentrated 
to 0.5 mL for NMR experiments. 
The protein was sequence identified by N-terminal Sequence and MALDI-MS. 
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 5.5 Characterization of 6P-1-VP15 
5.5.1 2-D NMR Experiments 
1H-15N-HSQC experiments were carried out on a Bruker AVANCE 500 MHz 
spectrometer equipped with pulse field gradients and cryo-probe. 15N uniformly labeled 
sample samples were contained in 5mm Shigemi NMR tube and the experimental 
temperature was kept at 4℃ .  
5.5.2 CD Experiments 
CD experiments were carried out on Jasco1-800 spectropolarimeter. In parameters 
settings, the scanned wavelength was set between 190nm to 260 nm and scanned 3 times 
for every sample. 200µL unlabelled sample of 6P-1-VP15 was loaded to the CD tube and 
the buffer was used as the reference spectrum.  
5.5.3 Gel Mobility Shift Assay 
The gel mobility shift assay was performed primarily as described by Ausubel 1995. 
An appropriate amount of different DNA fragments amplified by PCR from WSSV was 
added into the purified 6P-1-VP15. Some short oligonucleotides including single strand 
and double strand DNA (annealed by two single oligos) were also designed to react with 
the proteins.  The reaction mixtures were mixed and incubated at 4℃ for 2 hours, 
analyzed by 3% agarose gel electrophoresis and photographed under ultraviolet light. 
Annealing Oligo 
(a) Resuspending the Oligonucleotides: both complementary oligonucleotides were 
resuspended at the same molar concentration, using Annealing Buffer. 
(b) Annealing the Oligonucleotides: Equal volumes of both complementary oligos (at 
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equimolar concentration) were mixed in a 1.5mL microfuge tube and placed in a standard 
heatblock at 90 – 95℃ for 5 mins. After slow cooling to room temperature for 45-60 
minutes, the tubes were stored on ice or at 4℃ ready to use.  





















6. Result and Discussion 
6.1 PGEX-6P-1 Expression System 
183 bp DNA fragment encoding the proteins was PCRed out from WSSV genomic 
DNA (Fig2.6) and cloned into pGEX-6P-1 vector (N-terminal GST-tagged) (Fig.2.7) with 
restriction sites BamHI/XhoI. 
pGEX system is the most powerful system yet developed for the cloning and 
expression of recombinant proteins in E. coli. GST fusion proteins are produced in E. coli 
cells containing a recombinant pGEX-6P-1 plasmid. Protein expression from a pGEX 
plasmid is under the control of the tac promoter, which is induced using IPTG. Target 
genes are cloned in pGEX plasmids under control of strong bacteriophage T7 promoter; 
expression is induced by providing a source of T7 RNA polymerase in the host cell. T7 
RNA polymerase is so selective and active that, when fully induced, almost all of the cell 
resources are converted to target gene expression; the desired product can reach more 
than 50% of the total cell protein a few hours after induction. Although this system is 
extremely powerful, it is also possible to attenuate expression levels simply by lowering 
the concentration of IPTG. Decreasing the expression level may enhance the yield of the 
soluble fraction of some target proteins. Once established in a non-expression host e.g. 
DH5α, target protein expression may be initiated by transferring the plasmid into an 
expression host containing a chromosomal copy of the T7 RNA polymerase gene under 
lac operator control. In this case, expression is induced by the addition of IPTG to the 
bacterial culture. Two types of T7 promoter and several hosts that differ in their 
stringency of suppressing basal expression levels are available, providing great flexibility 

































































Some other different expression systems were also been tried to express this VP15 
protein such as pET and secreted system. However, the protein was either not expressed 
or expressed in minimal quantiting to warrant any further study. 
6.2  Expression and Purification of the Protein 
DNA sequence analysis confirmed that plasmid 6P-1-VP15 was transformed into 
BL21 cell for expression. At 37℃, when the cells grow to the exponential phase, the 
production of GST-tagged VP15 could be induced by adding IPTG to a final 
concentration of 0.5 mM. After the cells were lysed by sonication and centrifugation, 
GST-VP15 was released into the supernatant due to its high hydrophilicity. 
GST Affinity Chromatography  
Fusion proteins were purified from bacterial lysates by affinity chromatography 
using Glutathione Sepharose 4B. This affinity chromatography step was used to remove 
most of the contaminating proteins to facilitate the later purification steps. Unbound 
protein was removed by washing the column extensively with binding buffer. Elution 
buffer containing 20 mM GSH was used to elute the bounded GST-tagged protein from 
beads. This single step using GST affinity chromatography can improve the purity of the 
proteins to above 80%.(Fig.2.8) 
SDS-PAGE technique is used to assess the purity and to estimate the molecular 
weight of the protein. 
The pGEX-6P-1 plasmids were for inducible, high level intracellular expression of 
genes or gene fragments as fusions with Schistosoma japonicum GST. GST occurred 
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Fig.2.8 Protein Expression and GST Affinity Column Purification  
(1) Low molecular weight marker; (2)Total protein extract of non-induced culture; (3)Total 
protein extract of induced culture containing GST-VP15 fusion protein; (4)Inclusive body after 
dialysis and centrifugation step; (5) Supernatant after 18,000 rpm centrifugation step; (6) 
(Flow-through fraction from GST affinity column; (7) 6P-1-VP15 eluted by 20 mM GSH from 





















Cleavage recognition sequence was located immediately upstream from the multiple 
cloning site on the pGEX-6P-1 plasmids. 
Precession Cleavage 
Following the elution of the GST fusion protein, eluate was dialyzed the extensively 
against PreScission Cleavage Buffer in order to remove reduced glutathione from the 
sample. 1 µL (2 U) of PreScission Protease was added for each 100 µg of fusion protein 
in the eluate and incubated at 5℃ for overnight. (Fig.2.9) 
PreScission Protease is a fusion protein of GST and human rhinovirus 3C protease. 
The protease specifically recognizes the amino acid sequence Leu-Glu-Val-Leu- Phe-Gln 
¯ Gly-Pro cleaving between the Gln and Gly residues. Since the protease is fused to GST, 
it is easily removed from cleavage reactions using Glutathione Sepharose.  
Once digestion was complete, the sample was loaded to a washed and equilibrated 
Glutathione Sepharose column to remove the GST portion of the fusion protein and the 
PreScission Protease from the protein of interest. (Fig.2.10) 
Ion Exchange Chromatography 
The last SP Sepharose cation chromatography was used to remove the other 
remaining contaminating proteins (Fig.2.11). SDS-PAGE showed that single peak 
composed entirely of the VP15, with the purity above 95% was obtained. At this stage, 
the protein was normally pure enough for NMR analysis. 
From the data, VP15 migrated as a 15KDa protein on SDS-PAGE instead of its 
expected 7 KDa Molecular weight. That is probably because the protein has an extremely 
basic pI value of 13.2 due to its amino acid composition rich in lysine (22 %), arginine 
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Fig.2.9 Protein Digestion of PreScission   











































1       2            3    
Fig.2.10 Remove GST and Enzyme   
(1) Sample after protease digestion; (2) and (3) different eluted fraction after 
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Fig.2.11 Final purified by SP Sepharose 

























have an apparent molecular weight because basic amino acids are highly attracted to the 
negative charge on SDS, resulting in the increase of the mass:charge ratio of the 
SDS-protein complex, thus lowering electrophoretic mobility. 
On-Column Purifcation 
 
Based on the characteristics of PreScission Protease which is fused with GST, target 
proteins can be purified using either on-column purification or digestion following 
elution from the matrix (as stated above). As the latter method is more flexible, this 
method was chosen to purify the target proteins in the initial stage of experiment. 
However, on column digestion purification provides a more convenient way. The fusion 
protein can be digested with the appropriate site-specific protease while the fusion protein 
is bound to Glutathione Sepharose 4B. Cleavage of the bound fusion protein eliminates 
the extra step of separating the released protein from GST since the GST moiety remains 
bound to the matrix while the cloned protein is eluted using wash buffer. So this method 
was used mostly used to get the target protein. (Fig.2.12) 
Protein Identification 
The purified protein was identified by N-terminal Sequence Determination and 
MALDI-MS Molecular Weight Analysis. 
Expected: Sequence of Expression Protein: 
(cleavage site)G  P  L  G  S +(protein) V  A  R  S  S  K T  K  S  R  R  G  
S  K  K  R  S  T  T  A  G  R  I  S  K  R  R  S  P  S  M  K  K  R  
A  G  K  K  S   S  T  V  R  R  R  S  S  K  S  G  K  K  S  G  A  R  
K  S  R  R  *   
Theoretical Mw: 7102.26 D 
 














Fig.2.12 On-column purification procedure 
 
(1)Low molecular weight marker; (2)Total protein extract of non-induced 
culture (3)Total protein extract of induced culture containing GST-VP15 
fusion protein; (4) Supernatant after 18,000 rpm centrifugation step; (5) 
Flow-through fraction from Glutathione Sepharose 4B column (6) Last wash 
fraction; (7) Cleavage product eluted after on-column digestion with 
PreScission Protease; (8) Flow-through fraction from SP Sepharose column; 

































Result of N-terminal sequence: Altogether 11 cycles was carried out from G to K 
(GPLGS+VARSSK), which matched the N-terminal sequence of target protein 
 
15N Labeled Protein Purification for NMR Study 
 
The advances of molecular biology techniques have facilitated the development of 
biomolecular NMR greatly. The various over-expression systems not only make the 
production of 13C, 15N labeled protein feasible, but also simplify the purification steps as 
well. The most commonly used method for isotopic enrichment of proteins is 
overexpression in E. coli using minimum medium containing 13C and 15N as the sole 
carbon and/or nitrogen source. E. coli can efficiently take up and incorporate into proteins 
exogenously supplied isotopically-labeled compounds into target proteins. The amino 
acid metabolic pathways of E. coli are also well understood, which allow them to be 
genetically blocked or altered if required to obtain the desired enrichment pattern.  
The 15N labeled VP15 migrated a little bit slower than unlabeled VP15 in 
SDS-PAGE (Fig.2.13) because its molecular weight was greater than the unlabeled one 
due to the incorporation of N15 label.  
Although the prokaryotic bacterial expression system can be widely used for protein 
expression, many eukaryotic proteins have been found to fold improperly in bacteria and 
therefore cannot be used for structural studies. Lack of post-translational modification, 
such as glycosylation, phosphorylation by the host E.coli is responsible for this 
phenomenon. In that situation, expression in yeast could be an alternative way to obtain 
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Fig 2.13 Purification of 15N labeled VP15 
Lane (1) (2): labeled 6P-1-VP15 fusion protein; (3) 15N labeled VP15 protein; 




































6.3 Characterization of VP15 
6.3.1 Prediction of VP 15 Secondary Structures  
   
Amino Acid:  
 
Secondary   
Structure: 
10|              20|                30| 
MVARSSKTKS   RRGSKKRSTT    AGRISKRRSP 
 
CCCCCCCCCC  CCCCCCCCCC    CCCECCCCCC 
Amino Acid: 
 
Secondary   
Structure: 
40|               50|               60| 
SMKKRAGKKS   STVRRRSSKS    GKKSGARKSR 
 
CCCHCCCCCC   EEEEECCCCC    CCCCCCCCCC 
From prediction, VP15 was mostly composed of random coil and it probably was an 
unstructured protein. 
6.3.2 CD spectra of VP15 
CD (Circular Dichroism) is a quick, low resolution technique for determining 
protein secondary structure. CD experiment was carried out to analyze the secondary 
structure of VP15. The buffer was used a control. (Fig.2.14) 
CD spectra between 260 and approximately 180 nm (Far UV-CD) can be analyzed for the 
different secondary structural types of proteins: alpha helix, parallel and antiparallel beta 
sheet, turn, and other. For a folded protein, its secondary structure can be detected from 
different peaks: 
z Far UV-CD of Random Coil (RC): 
Positive at 212 nm      Negative at 195nm 
z Far UV-CD of β-sheet: 
Positive at 197 nm      Negative at 218nm 
z Far UV-CD α-helix: 


























































However, from the spectra (Fig.2.14), no significant difference can be traced 
between the protein and the control. Even in different buffers (Fig.2.15), no structural 
change was observed. The difference among all curves was mostly before 205nm, which 
was effected by different salt conditions. The CD data here suggested that VP15 was a 
poorly-folded protein and was consistent with the predicted result. 
6.3.3 2D 1H-15N HSQC Spectrum 
Two-dimensional NMR specta can explore and exploit two types of interactions 
(“through-bond coupling” and “through-space coupling”) between same (homo) or 
different (hetero) nuclei in a molecule to get very useful conformational information. 
The 1H-15N HSQC (Heteronuclear Single-Quantum Correlation) is a 2D experiment 
with one 1H frequency and one 15N frequency. Each amino acid residue (except proline) 
gives one signal that corresponds to the N-H amide group. Depending on pH and solvent 
exposure side chain NHx groups can be visible, too. Folded Proteins or protein domains 
display a broad distribution of NMR frequencies resulting in a good spread-out of signals 
in the 15N-HSQC spectra. Unfolded amino acid residues share similar NMR frequencies 
resulting in heavy overlap of signals. 
The HSQC experiment is in fact a double INEPT experiment. This experiment 
correlates protons with their directly attached heteronuclei. Proton magnetization is 
detected while the low-gamma nuclei evolved during the evolution time. Because of the 
detection of the high frequency nuclei, this sequence is very sensitive, so 1H-15N HSQC 
experiment was carried to further analyze and identify the secondary structure of VP15. 
1H-15N HSQC Spectra was collected for 15N isotope-labeled samples and the broad 
resonance peaks were obtained, which resulted in poorly dispersed HSQC spectra 
 67























































































Fig.2.15 CD spectra of VP15 in different buffers 
 
1. 500mM NaCl,20mM Tris, pH. 9.5        4.500mM NaCl,20mM Tris, pH. 7.0 
2. 250mM NaCl,10mM Tris, pH. 9.5        5.250mM NaCl,10mM Tris, pH. 7.0 
3. 50mM NaCl,10mM Tris, pH. 9.5         6. 50mM NaCl, 10mM Tris, pH. 7.0 
 
7.500mM NaCl,20mM Tris, pH. 4.0 
8.250mM NaCl,10mM Tris, pH. 4.0 






















































6.3.4 DNA-Protein Interaction and Gel Mobility Shift  
VP15 was a major structural protein of WSSV. However, its secondary structure 
was mostly composed of random coil based on above result.  
VP15 had a strong positive charge along the whole length of the polypeptide. A 
putative function for this highly basic protein is that of a histone-like, DNA-associated 
protein. Its small size, positive charge and its presence within the nucleocapsid fraction 
are in agreement with this hypothesis. The DNA-Protein interaction capability might be 
important in DNA packing and understanding how it gives rise to the precise assembly 
pathway from this interaction. The capability of VP15 to bind DNA was tested and gel 
mobility shift was carried out to select the binding site if there was any. Also, it was 
important to investigate whether there are any major structural conformational changes 
associated with the binding of VP15 to DNA. 
The gel shift, or electrophoretic mobility shift assay provides a simple and rapid 
method for detecting DNA-binding proteins. It is based on the differential mobility of 
free DNA and DNA-protein complexes in native (non-denaturing) polyacrylamide or 
agarose gels. It could be observed that complexes of protein VP15 and DNA migrated 
more slowly than free DNA fragments through agarose gel (Fig.2.17), which suggested 
that VP15 was a DNA binding protein and didn’t select specific DNA sequence to bind. 
As control, there was no migration observed in protein A with DNA fragments (Fig.2.18).  
Furthermore, the assay was also performed by incubating a purified protein with 
ssDNA( single strand DNA) and dsDNA (double strand DNA). From the Fig.2.19, no 








1     2     3     4     5    6     7     8    9  
Fig.2.17 Different DNA fragments and DNA fragments/VP15 mixture  
 













1      1’ 2       2’ 3     3’ 4         4’ 5     5’ 6     6’
7      7’ 8       8’ 9     9’ 10    11’ 12    12’ marker  
Fig.2.18 VP15/DNA mixture and Protein A/DNA mixture as control 
 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, control protein A with different ORF of 
WSSV; 













1         1’ 2        2’ 3      3’ 4       4’ 5        5’ 6        6’ marker
7         7’ 8        8’ 9      9’ 10    10’ 11     11’ 12   12’ marker
 
Fig.2.19 VP15/ssDNA oligos and VP15/dsDNA oligos 
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, VP15 with dsDNA 












From the above experiments, we could see that VP 15 was a non-specific dsDNA 
binding protein. In above films, some of DNA bands with VP15 were missing. It was 
probably because the DNA-protein complex was too big to enter the gel matrix. In 
additional, it also may because of the incorrect protein: DNA ratio. The amount of protein 
should be carefully titrated to get a satisfactory result. 
The structural status of VP15 with DNA was checked by CD. However, from 
Fig.2.20, no significant difference was observed in wavelength 200nm—260 nm between 
protein alone and protein with DNA. The difference before 200nm may be interfered by 






















































7. Conclusion and Future Work 
7.1 Conclusion 
This study aimed to characterize the nucleocapsid proteins of white spot syndrome 
virus. VP15 was the major capsid protein of WSSV. The full length protein VP15 was 
cloned and expressed in E. coli and first purified by GST-affinity chromatography and 
further purified using ion exchange chromatography. The same expression system and 
purification steps were employed to produce heavy isotope labeled sample for the NMR 
studies. 
The Secondary structure analysis based on CD spectra and 2-D NMR spectra 
indicated that this protein VP15 was a random coil. This protein was further characterized 
by gel mobility shift assay and the result showed that it was a non-specific DNA binding 
protein. However, it only interacted with double stand DNA instead of single strand DNA. 
Further more, there was no distinct difference between 2-D structures of the protein and 
protein with DNA from CD spectra.   
7.2 Future work 
1. To study the protein VP15 in vivo and elucidation the structure of the native protein. It 
is important to characterize the native structure of VP15, whether there is any 
post-translative modification of the protein.    
2.  Assembly of the nucleocapsid by protein-protein, protein-DNA interaction in vitro. It 
is needed to study these interactions under conditions closely approaching those in 
vivo inside the cell (N.J.Dimmock et al, 1946). Since pH and ionic strength play an 
important role on the formation of aggregates of capsid proteins, they need to be 
carefully adjusted in order to achieve the capsid proteins in vitro assembly. With the 
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complexes formed in these interactions, the dynamic nature, processivity, and high 














































CHAPTER 3. NUCLEOCAPSID PROTEIN VP24 OF WSSV 
1. Summary 
cDNA of VP24 was subcloned into pGEX-6P-1 vector and overexpressed as a GST 
fusion protein. Due to the strong hydrophobic domain in N-terminal, the expressed 
protein occurred as insoluble inclusion body. Its solubility in different detergents with 
different concentrations was compared. Lysis buffer containing 0.3% N-laurylsarcosine 
(sarkosyl) was chosen in which the protein exhibited a high solubility. After obtaining the 
soluble protein, affinity chromatography was used for its purification. Antibody of this 
protein was generated by purified protein. It was used as antigen to immunize mice by 
intra dermal injection. Antibody was generated by this method and can be used to further 
identify the location of this protein in WSSV virions in order to distinguish the difference 





















2. Introduction to VP24  
2.1 Characterization of VP24 and Its Similarity with VP26 and VP28 
VP24 ORF, encompassing 627nucleotides, encodes 208 amino acids. Computer 
analysis of the 208 amino acids showed that a strong hydrophobic region was present at 
the N-terminus of VP24 (Fig.3.1), including a putative transmembrane a-helix formed by 
amino acids 6 through 25. The algorithm of Garnier et al., (1978) predicted several other 
α-helices and β-sheets along the protein. It is remarkable that VP28, VP26 and VP24 
roughly have the same size (206 amino acids) but have distinct electrophoretic mobilities. 
This may be due to differences in isoelectric points, conformational differences or 
post-translational modifications. Homology searches with WSSV VP24 were performed 
against GenBank, EMBL, SWISS-PROT and PIR databases using FASTA, TFASTA and 
BLAST, but no significant homology with structural proteins from other large DNA 
viruses could be found. Surprisingly, statistically significant similarity was found with the 
sequence of two other WSSV virion structural envelope proteins, VP26 and VP28 (Van 
Hulten et al., 2000), with 41 and 46% amino acid similarity, respectively. An alignment 
of the three WSSV proteins was made using ClustalW (Thompson et al., 1994), and 
revealed several conserved regions (in the hydrophilicity plots (Fig. 3.1). These residues 
might represent a transmembrane region Fig3.2). In the N-terminal region a well 
conserved stretch of amino acids is observed at positions 15±30. A strong hydrophobic 
region with a a-helix is observed for all three proteins, or be involved in the interaction of 
the structural proteins to form homo- or hetero- multimers. In two other conserved 
regions, around positions 88±102 and positions 138±148, the algorithm of Garnier et al 
(1978) predicted a α-helices and β-sheets for all three proteins. (Fig3.1 and 3.2) 
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Fig.3.1 Hydrophilicity plots of WSSV VP24, VP26 and VP28  
(The amino acid number is on the abscissa, and the hydrophilicity value on 




































Fig.3.2 Amino acid sequence alignment of VP24, VP26and VP28 (shading 
is used to indicate the occurrence (black 100%, grey 67%) of similar amino 











Two-thirds of the residues conserved in the three proteins were hydrophobic and 
might be involved in the folding of the proteins, giving them a similar structure. The 
nucleocapsid protein VP24 had a basic character with isoelectric points 8.7, whereas the 
envelope protein (VP28 and VP26) were more acidic. As there is a high homology at the 
amino acid level among the three structural WSSV proteins, and conserved domains are 
present, there is reason to believe that their structures are similar. The presence of the 
hydrophobic domain indicates that these proteins most probably are capable of forming 
homo and hetero multimers. Studies on the interaction of these proteins and their location 
in the virion are required to substantiate this hypothesis. A way to explain the high degree 
of amino acid similarity of the three structural WSSV proteins is to assume that these 
genes have evolved by gene duplication. Nucleotide comparisons supported this 
hypothesis, as significant homology was found. Alignment of VP24, VP28 and VP26, 
revealed that VP24 has 40% nucleotide identity with VP26 and 43% with VP28, whereas 
VP26 has 48% nucleotide identity with VP28. The data presented here strongly suggest 
that these three WSSV structural protein genes share a common ancestor. The most 
surprising observation might be that these proteins have evolved to give proteins with 
different functions in the WSSV virion, i.e. in the nucleocapsid and the envelope. Such a 
situation is unusual in animal DNA viruses, although a parallel may exist for the virion 
glycoproteins of alpha herpes viruses as their genes might have evolved by duplication 





2.2 Studies on VP24 
This study aims to select proper cloning and expression system to express VP24 and 
develop the proper protocol to solubilize this protein and identify the location of this 
protein in WSSV virions, which is very important to further elucidate the structure of this 




















3. Material and Method 
3.1 PCR Amplification of Gene VP24 
VP24 DNA Sequence  
atgcacatgt ggggggttta cgccgctata ctggcgggtt tgacattgat actcgtggtt 
atatctatag ttgtaaccaa catagaactt aacaagaaat tggacaagaa ggataaagac 
gcctaccctg ttgaatctga aataataaac ttgaccatta acggtgttgc tagaggaaac 
cactttaact ttgtaaacgg cacattacaa accaggaact atggaaaggt atatgtagct 
ggccaaggaa cgtccgattc tgaactggta aaaaagaaag gagacataat cctcacatct 
ttacttggag acggagacca cacactaaat gtaaacaaag ccgaatctaa agaattagaa 
ttgtatgcaa gagtatacaa taatacaaag agggatataa cagtggactc tgtttcactg 
tctccaggtc taaatgctac aggaagggaa ttttcagcta acaaatttgt attatatttc 
aaaccaacag ttttgaagaa aaataggatc aacacacttg tgtttggagc aacgtttgac 
gaagacatcg atgatacaaa taggcattat ctgttaagta tgcgattttc tcctggcaat 
gatctgttta aggttgggga aaaataa 
 
The 627 bp gene was PCR amplified by two primers (5’-: CGC GGA TCC CAC 
ATG TGG GGG GTT TAC -3’ and 5’- CGC CCG CTC GAG TTA TTT TTC CCC AAC 
CTT AAA C -3’) from the pGEX-6P-1vector. The primers used in the PCR were specially 
designed to incorporate XhoI and BamHI restriction sites to the flanks of the VP24 
fragment for subsequent cloning into the expression vectors.  
3.2 Construction of 6P-1-VP24  
627 bp DNA fragment encoding the proteins was PCRed out from WSSV genomic 
DNA and cloned into pGEX-6P-1 vector (N-terminal GST-tagged) with restriction sites 
BamH1/XhoI. 
3.3 Expression System of 6P-1-VP24 
3.3.1 Transformation Plasmid 6P-1-VP15 into Expression Competent Cell BL21 
(DE3) 
3.3.2 Determination of Target Protein Solubility 
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A single colony was picked up from plate to inoculate 5 ml LB medium containing 
100ug/mL ampicilin (LBA) and grown overnight at both 37℃ and 30℃ with shaking. 
2.5 mL overnight culture was further inoculated into 50 mL LBA and grown with 
vigorous shaking until the OD600 was about 0.5. 1 mL sample (non-induced control) was 
taken out, centrifuged and resuspended in 50 µL SDS-PAGE sample buffer. IPTG was 
added to the rest of culture to a final concentration of 0.5 mM to induce protein 
expresssion for further 3-3.5 hours. 1 mL sample was collected, centrifuged and 
resuspended in 100 µL SDS-PAGE sample buffer. The rest of culture was harvested and 
centrifuged at 5000 rpm for 10 minutes at 4℃. The cell pellet was resuspended in 5 mL 
lysis buffer and further sonicated thoroughly. The lysate was centrifuged at 16000 rpm for 
20 minutes. 100 µL supernatant (soluble) was taken out and added to 100 µL 2 × 
SDS-PAGE sample buffers. Aliquot (insoluble protein) was resuspended in 200 µL 1× 
SDS-PAGE sample buffer.  
All the 8 samples were boiled for 5 minutes and microcentrifuged. 10 µL of 
supernatant was loaded into each lane of the SDS-PAGE gel. 
3.3.3 Preparation of Inclusion Bodies 
Inclusion bodies were isolated from the crude cell lysate by centrifugation and 
washed twice with 1X IB Wash Buffer (20 mM Tris-HCl pH 7.5, 10 mM EDTA, 1% 
Triton X-100)  to remove loosely associated contaminants.  
The induced culture was harvested by centrifugation at 5,000 rpm for 15 min at 4℃. 
The supernatant was removed and discarded. The cell pellet then was thoroughly 
resuspended in 0.1 culture volume of 1X IB Wash Buffer and mixed for full resuspension. 
Subsequently the suspension was cooled on ice to 4℃ to prevent heating during cell 
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breakage. Lysozyme was added to a final concentration of 100 mg/mL from a freshly 
prepared 10 mg/mL stock in water. It was then incubated at 30℃ for 15 min followed by 
swirling and sonicating on ice with an appropriate tip until cells were lysed and the 
solution was no longer viscous. Samples were kept cold to prevent proteolytic 
degradation of the target protein. The inclusion bodies were collected by centrifugation at 
16,000 rpm for 30 min. The supernatant was removed and the pellet was thoroughly 
resuspended in 0.1 culture volume of 1X IB Wash Buffer, centrifuged and thoroughly 
resuspended in 0.1 culture volume of 1X IB Wash Buffer again. The suspension was 
transferred to a clean centrifuge tube with known tare weight. The inclusion bodies were 
collected by centrifugation at 16,000 rpm for 10 min. The supernatant was decanted and 
by tapping the inverted tube on a paper towel the last traces of liquid was removed. The 
tube was weighed and the wet weight of the inclusion bodies was obtained by subtracting 
the tare weight.  
3.3.4 Solubilization and Refolding 
From the wet weight of the inclusion bodies to be processed, the amount of 1X IB 
Solubilization Buffer (50 mM CAPS, pH 11.0) necessary was calculated to resuspend the 
inclusion bodies at a concentration of 10–20 mg/ml. At room temperature, the calculated 
volume of 1X IB Solubilization Buffer supplemented with 0.3% N-lauroylsarcosine was 
prepared. The calculated amount of 1X Solubilization Buffer/N-lauroylsarcosine from 
above was added to the inclusion bodies and gently mixed. Large debris can be broken up 
by repeated pipetting and incubated at room temperature for 15 min. The sample was 
clarified by centrifugation at 16,000 rpm for 30 min at room temperature. The supernatant 
containing the solubilized protein was transferred into a clean tube, avoiding pelleted 
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debris.  
3.3.5 Dialysis Protocol for Protein Refolding 
Dialysis was performed at 4℃ for 4 hours each with at least two buffer changes of 
greater than 50 times the volume of the sample (20 mM Tris-HCl, pH 8.5). The dialysis 
was continued through two additional changes (4 h each) with the dialysis buffer lacking 
DTT. 
3.4 Protein Purification by Glutathione S-Transferase Affinity 
Chromatography 
The soluble denatured protein was loaded into a 2ml GST resin column which had 
been equilibrated with binding buffer. After the GST-tagged protein was bound onto the 
resin, the resin was further washed thoroughly with 30 ml washing buffer until the 
absorption at 280 nm of the washing was very low. GST-tagged protein can be eluted out 
by a small amount of elution buffer [20mM Tris-HCl, 20mM reduced glutathione pH 8.5 
(adjusted by Tris)]. For every step, 0.5 ml sample was collected and boiled with SDS 
loading buffer to be further checked by SDS-PAGE. 
3.5 Identification by MALDI-MS (matrix assisted laser desorption 
ionization) 
The band of the fusion protein was cut off from the gel and was cut into fine piece. 
In-gel digestion was performed by trypsin and the sample was analyzed by MALDI-MS 
and searched the result by MS-FIT. 
3.6 Preparation of Antibody  
1. The purified 6P-1-VP24 fusion protein was used as antigen to immunize mice by 
intradermal injection once every 2 weeks over an 8-week period. Antigen (5 µg) was 
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mixed with an equal volume of Freund's complete adjuvant (Sigma) for the first injection. 
Subsequent injections were conducted using 5 µg of antigen mixed with an equal volume 
of Freund's incomplete adjuvant (Sigma).  
2. Four days after the last injection, mice were exsanguinated, and antisera collected. The 
titres of the antisera were 1:20000 as determined by ELISA. ELISA was performed 
essentially as described by Harlow & Lane (1998). The immunoglobulin (IgG) fraction 
was purified by protein A–Sepharose (Bio-Rad) (Sambrook et al., 1989) and stored at –70 
°C. The optimal dilution of purified IgG, after serial dilutions, was 1:1000, as determined 
by ELISA.  
3.6.1 Western Blot Protocol 
The sample was performed electrophoresis and proteins were transferred to Hybond 
ECL (Transfer Buffer: 12mM Tris-HCl, pH 8.3, 96mM glycine, 20% (v/V methanol). 
At this step, non-specific binding sites were blocked by immersing the membrane in 
Blocking solution (Blocking solution: 2% (w/V) fatty aicd –free bovine serum albumin 
(BSA) in Wash solution) for 1 hour at room temperature on an orbital shaker followed by  
rinsing membrane for 2x2 minutes of wash buffer (Wash solution: PBS-Tween 0.01% 
(v/v) Tween 20 in PBS ). 
The primary antibody was diluted 1:2000 in blocking solution and the membrane 
was incubated in diluted primary antibody for 3 hours at room temperature on an orbital 
shaker. After rinsing the membrane with three changes of wash buffer (5 minutes for each 
change), the membrane was further incubated with diluted HRP labeled secondary 
antibody for 1 hour at room temperature on the orbital shaker. Another 3 times (5mins 
each) changes of fresh wash solution to membrane were carried out and finally the signal 
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4. Result and Discussion 
4.1 Construction Plasmid of 6P-1-VP15 
627 bp DNA fragment (Fig.3.3) encoding the proteins was PCRed out from WSSV 
genomic DNA (Fig2.6) and cloned into pGEX-6P-1 vector with restriction sites 
BamH1/XhoI. 
4.2 6P-1-VP24 Was Expressed As Inclusion Bodies 
In some cases, fusion protein solubility can be dramatically increased by lowering 
the growth temperature. Experiment with growth temperatures in the range of 20 to 30℃
was tried combined with altering level of induction by decreasing IPTG concentration to 
0.1 mM. 
At both 37℃ and 25℃, when the cells grew to the componential phase, the 
production of GST-tagged VP24 could be induced by adding IPTG to the concentration in 
the arrange of 0.1 mM to 1 mM. After the cells were lysed by sonication and 
centrifugation, 6P-1-VP24 was expressed as the inclusion bodies (Fig3.4). 
Bacterial expression has greatly expanded the biochemical analysis of many proteins. 
However, the great drawback of the bacterial system has been the accumulation of many 
expressed proteins in a highly insoluble form (Stewart, 1990). In some case, other 
expression systems such as yeast and baculovirus expression systems can be alternatively 
used to yield soluble protein. However, for VP24 no cysteine is present in its amino acid 
sequence so it should not make much difference even using different system to express 
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Fig.3.4 6P-1-VP24 was expressed as inclusion bodies.  
Lane (1) Whole cell before induction at 37℃ (2) Whole cell after 3 hours  
IPTG induction at 37℃ (3) The pellet of cell lysate after induction at 37℃ 
(4) The supernant of the cell lysate after induction at 37℃ (5) Whole cell 
before induction at 25℃ (6)Whole cell after 3 hours induction at 25℃ (7) 
The pellet of cell lysate after induction at 25℃ (8) The supernant of the cell 










Over-expression of target protein in E coli as inclusion bodies has some advantages 
over
e Fusion-Protein 
erformed in-gel digestion and identified by in 
MAL
h result of MS-FIT (Tab.3.1), the Mouse score is quite high for 
the t
in Different Denaturants   
different denaturants 
with
ure temperature (at alkaline pH) can 
cova
 
 cytoplasmic or periplasmic expression in both fields of research and manufacturing. 
Inactivation of over-expressed heterologous protein as inclusion bodies enables host cells 
to accumulate large amount of protein products without any cytotoxicity to the cell. The 
highly aggregated form of protein in inclusion bodies also protects it from proteolytical 
degradation. Inclusion bodies also simplify the downstream purification process since 
most contaminating proteins in the soluble fraction can be discarded during the 
pre-column steps. 
4.3 Identity of th
The expressed protein was cut off, p
DI-MS (Fig.3.5). 
Based on the searc
op three searches in protein bank (all are protein VP24 in different name in different 
database). The result confirmed that the expressed fusion GST-fusion protein was 
6P-1-VP24. 
4.4 Solubility of 6P-1-VP24 
In order to obtain the best conditions to solubilize this protein, 
 different concentrations were tried (Fig3.6).  
Denaturants’ concentration and different cult
lently modify primary amines on the target protein. N-lauroylsarcosine ( Sarkosyl ) 
is a sodium salt of alkyl anionic detergent(Fig3.7). It can be used to solubilize most, if not 
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Fig3.6b Solubility ain different detergents  


























































4.5 Protein Refolding  
The intermolecular association of hydrophobic domain during folding is believed to 
 of inclusion bodies. For proteins with cysteine/cysteine 
residues, improper formation of disulphide 
optim
reagent, and refolding methods. Refolding at a low protein 
concentratio
n to remove the most 
play a role in the formation
bonds in the reducing environment of the E. 
coli cytoplasm may also contribute to incorrect folding and formation of inclusion bodies. 
Fortunately, there is no cysteine reside in this protein. 
In order to restore the protein to its unique, functional, three-dimensional 
conformation from inclusion bodies, the denaturing and refolding steps would need to be 
ized for each protein on a case-by-case basis. Two denaturants are usually 
employed to solubilize the inclusion bodies, namely guanidine hydrochloride and urea. 
Guanidine hydrochloride is a more powerful denaturant than urea, and its solubilizing 
effect on different chemical groups in proteins is different from that of urea. However, it’s 
very complicated to check the protein status with this denaturants. N-lauroylsarcosine 
does not impair refolding and purification, the residual detergent level following dialysis 
is often 100-fold lower than the concentration in the solubilization step, typically less 
than 0.003%. 
Many factors will affect the recovery rate of refolding such as protein concentration, 
temperature, cosolvents, thiol 
n will generally increase the yield of soluble protein but subsequent protein 
concentration will be tedious. As to the refolding methods, rapid dilution or slow dialysis 
can be used and they have their own advantages over each other. 
4.6 Purification of the Protein by GST Affinity Column 
The dialyzed protein was loaded to GST affinity colum
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contaminant proteins. The result was showed in Fig.3.8. 
In the process of expression, the GST alone was expressed. So the GST expressed 
was bound to the affinity column too and was eluted down with the GST-fusion protein. 
Furth
 be investigated from the result of 
west
polyclonal antibody of VP24 was quite specific and 
the s
 
er purification steps are needed if more purity is needed. However, since no GST 
existed in WSSV virus, the fusion protein with GST as the antigen to immunize mouse 
had few effect to the polyclonal antibody. 
 4.7 Production of Antibody of 6P-1-VP24 
The produced 6P-1-VP15 was used as antigen to obtain the polyclonal antibody 
from mouse. The specificity of this antibody could
ern blot assay below (Fig.3.9)  
The result proved that VP24 is one the of major WSSV structure proteins. The 
western blot assay showed that this 
pecificity will be enough to carry out the immuno-electron Microscope studies to 
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ig.3.8 Purification of the protein by GST affinity column 
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 ig.3.9 Identify the specificity of Anti-VP24 by western blots 
irion: WSSV virion ; protein: 6P-1-VP24 fusion protein 










5. Future Work 
. Due to the statistically significant similarity with the sequence of two identified 





identify the localization of VP24 in WSSV. 
2. The GST fusion protein need to be further purified by suitable chromatography after 
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